ILLUMINATIONS presented by RBC Wealth Management

Dr. Lori Brotto | Executive Director, WHRI

Dr. Lori Brotto is a Professor in the UBC Department of Obstetrics and Gynaecology, and a Registered Psychologist. She is the Executive Director of the Women’s Health Research Institute at BC Women’s Hospital. She is the director of the UBC Sexual Health Laboratory where research primarily focuses on advancing the science of psychological and mindfulness-based interventions for women’s sexual health. Her book, Better Sex Through Mindfulness: How Women Can Cultivate Desire is a knowledge translation of her research over the past 15 years demonstrating the benefits of mindfulness for women’s sexual concerns and genital pain.

Dr. Gigi Osler | 2019-2020 Immediate Past President, Canadian Medical Association

In 2018, Dr. Osler became the first female surgeon and the first woman of color to be elected as President of the Canadian Medical Association (CMA) – the national medical association representing medical students, residents and physicians across Canada. In recognition of this challenging national leadership role, she was named one of Canada’s Top 100 Most Powerful Women by the Women’s Executive Network in 2019. The CMA also recognized her inspiring leadership and named her a 2019 Physician Changemaker.

Dr. Gina Ogilvie | Canada Research Chair in Global Control of HPV-Related Disease at UBC

Dr. Ogilvie is a Tier 1 Canada Research Chair in Global Control of HPV related diseases and prevention. She is Assistant Director of the Women’s Health Research Institute, Senior Public Health Scientist at BC Centre for Disease Control and Senior Research Advisor at the BC Women’s Hospital and Health Centre. Dr. Ogilvie is principal investigator on over 20 million dollars in research grants focusing on both the public health and clinical aspects of reproductive health, sexually transmitted infections, HPV screening and the HPV vaccine. Her findings have been highly influential in setting and directing health policy in Canada and globally.

Gordon McCauley | President and CEO, adMare BioInnovations

Gordon McCauley was appointed President and CEO of adMare BioInnovations in 2017 after serving on the Board for four years. Mr. McCauley is an accomplished life science investor and executive.

He has served as President and CEO of Viable Healthworks Corp., a national healthcare service business; President and CEO of Allon Therapeutics Inc., a neuroscience biotechnology company that developed novel therapeutics; and Co-Founder and Partner of NDI Capital, an institutionally-backed life-science investment fund. Mr. McCauley has also been a senior executive of several successful health care enterprises and a senior advisor to several prominent Canadian political leaders.